These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 19581773

  • 1. Development of ocular myasthenia during pegylated interferon and ribavirin treatment for chronic hepatitis C.
    Kang HM, Park MJ, Hwang JM, Kim JW, Jeong SH.
    Korean J Hepatol; 2009 Jun; 15(2):209-15. PubMed ID: 19581773
    [Abstract] [Full Text] [Related]

  • 2. Myasthenia Crisis Induced by Pegylated-Interferon in Patient With Chronic Hepatitis C: A Case Report.
    Baik SJ, Kim TH, Kim HI, Rhie JY.
    Medicine (Baltimore); 2016 May; 95(21):e3782. PubMed ID: 27227948
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dual onset of type 1 diabetes mellitus and Graves' disease during treatment with pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.
    Hayashi M, Kataoka Y, Tachikawa K, Koguchi H, Tanaka H.
    Diabetes Res Clin Pract; 2009 Nov; 86(2):e19-21. PubMed ID: 19744739
    [Abstract] [Full Text] [Related]

  • 5. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
    Friedrich-Rust M, Theobald J, Zeuzem S, Bojunga J.
    J Viral Hepat; 2009 Mar; 16(3):168-77. PubMed ID: 19175874
    [Abstract] [Full Text] [Related]

  • 6. [A case of sudden-onset hearing loss in a patient treated with peginterferon alpha-2b and ribavirin for chronic hepatitis C].
    Shin MK, Kim TH, Ju K, Ha CY, Min HJ, Jung WT, Lee OJ.
    Korean J Hepatol; 2009 Sep; 15(3):370-4. PubMed ID: 19783887
    [Abstract] [Full Text] [Related]

  • 7. Combination pegylated interferon and ribavirin therapy precipitating acute renal failure and exacerbating IgA nephropathy.
    Gordon A, Menahem S, Mitchell J, Jenkins P, Dowling J, Roberts SK.
    Nephrol Dial Transplant; 2004 Aug; 19(8):2155. PubMed ID: 15252182
    [No Abstract] [Full Text] [Related]

  • 8. Peginterferon and ribavirin for hepatitis C.
    Evoli A, Servidei S.
    N Engl J Med; 2007 Mar 22; 356(12):1269-70; author reply 1271. PubMed ID: 17380575
    [No Abstract] [Full Text] [Related]

  • 9. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
    Rogers CJ, Romagosa R, Vincek V.
    J Am Acad Dermatol; 2004 Apr 22; 50(4):649-50. PubMed ID: 15034524
    [No Abstract] [Full Text] [Related]

  • 10. [Pegylated interferon and ribavirin associated retinopathy in patients with hepatitis C].
    Burgueño-Montañés C, Pérez-Álvarez R.
    Arch Soc Esp Oftalmol; 2011 Jun 22; 86(6):193-5. PubMed ID: 21767697
    [Abstract] [Full Text] [Related]

  • 11. Thyrotoxic periodic paralysis induced by pegylated interferon alpha plus ribavirin for chronic hepatitis C.
    Yang WS, Chu PL, Liu CH, Chung GB, Wu KD.
    J Clin Gastroenterol; 2008 Jan 22; 42(1):112-3. PubMed ID: 18097301
    [No Abstract] [Full Text] [Related]

  • 12. [Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C].
    Lee YN, Jeong SW, Lim JH, Ryu YS, Jeon SR, Kim SK, Jang JY, Kim YS, Kim BS, Roh MO.
    Korean J Hepatol; 2010 Jun 22; 16(2):187-91. PubMed ID: 20606504
    [Abstract] [Full Text] [Related]

  • 13. Alopecia universalis: a rare side effect seen on chronic hepatitis C treatment with peg-IFN and ribavirin.
    Demirturk N, Aykin N, Demirdal T, Cevik F.
    Eur J Dermatol; 2006 Jun 22; 16(5):579-80. PubMed ID: 17101483
    [No Abstract] [Full Text] [Related]

  • 14. Commentary: efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C - authors' reply.
    Hu CC, Chien RN.
    Aliment Pharmacol Ther; 2013 Feb 22; 37(4):492. PubMed ID: 23336679
    [No Abstract] [Full Text] [Related]

  • 15. Development of Myasthenia gravis due to treatment of chronic hepatitis C with a combination of interferon-alpha and ribavirin.
    Bektas M, Bektas H, Gören D, Altan M, Cetinkaya H.
    Digestion; 2007 Feb 22; 75(4):208-9. PubMed ID: 17934275
    [No Abstract] [Full Text] [Related]

  • 16. Exacerbation of oral lichen planus lesions during treatment of chronic hepatitis C with pegylated interferon and ribavirin.
    Grossmann Sde M, Teixeira R, de Aguiar MC, do Carmo MA.
    Eur J Gastroenterol Hepatol; 2008 Jul 22; 20(7):702-6. PubMed ID: 18679075
    [Abstract] [Full Text] [Related]

  • 17. [Pegylated-interferon alpha plus ribavirin-induced subacute thyroiditis in chronic hepatitis C].
    Abellán Galiana P, Pérez-Lázaro A, Aguilera Sancho-Tello V, Merino Torres JF, Berenguer Haym M, Piñón Sellés F.
    Endocrinol Nutr; 2009 Mar 22; 56(3):136-9. PubMed ID: 19627727
    [Abstract] [Full Text] [Related]

  • 18. [Bilateral non-arteritic ischemic optic neuropathy during treatment of viral hepatitis C with pegylated interferon and Ribavirin].
    Iferkhass S, Elasri F, Chatioui S, Khoyaali A, Bargach T, Reda K, Oubaaz A.
    J Fr Ophtalmol; 2015 Jan 22; 38(1):34-40. PubMed ID: 25533994
    [Abstract] [Full Text] [Related]

  • 19. Ischemic colitis during pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.
    Leung Y, Urbanski SJ, Schindel L, Myers RP.
    Can J Gastroenterol; 2006 Oct 22; 20(10):661-3. PubMed ID: 17066158
    [Abstract] [Full Text] [Related]

  • 20. Chronic hepatitis C genotype 6 responds better to pegylated interferon and ribavirin combination therapy than genotype 1.
    Tsang OT, Zee JS, Chan JM, Li RS, Kan YM, Li FT, Lo FH, Chow DA, Cheung KW, Chan KH, Yeung YW, Ng FH, Li MK, Kwan WK, Lai TS.
    J Gastroenterol Hepatol; 2010 Apr 22; 25(4):766-71. PubMed ID: 20492332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.